| | Public Health & Safety | CPR
Stage 4 (Very Severe) Emphysema/COPD: Clinical Features, Complications, and Management Paradigms
GOLD Stage 4 COPD (FEV₁ <30% predicted or FEV₁ <50% with chronic respiratory failure) represents end-stage obstructive lung disease with profound functional limitation and high mortality risk.
Defining Physiologic Impairment
- Spirometry: FEV₁ <30% predicted; FEV₁/FVC <0.70; often irreversible.
- Hyperinflation: RV >140% predicted; TLC >120%; IC/TLC <25%.
- Gas exchange: Chronic hypoxemia (PaO₂ <60 mmHg), often hypercapnia (PaCO₂ >45 mmHg).
Clinical Manifestations
- Dyspnea at rest or minimal exertion (mMRC grade 3–4)
- Chronic productive cough; frequent purulent exacerbations
- Weight loss, muscle wasting (cachexia), sarcopenia
- Sleep disruption (nocturnal hypoxemia, orthopnea)
- Psychologic burden: anxiety, depression, social isolation
Major Complications
| Complication | Mechanism | Management |
|---|---|---|
| Respiratory failure | Ventilatory pump failure + gas exchange failure | NIV (BiPAP), invasive ventilation, tracheostomy |
| Pulmonary hypertension / Cor pulmonale | Hypoxic vasoconstriction → RV hypertrophy → RV failure | LTOT, diuretics, anticoagulation, pulmonary vasodilators (selected) |
| Recurrent pneumonia | Impaired clearance, immune dysfunction, steroid use | Vaccination (PCV20, PPSV23, influenza, RSV), prompt antibiotics |
| Osteoporosis/fracture | Systemic steroids, immobility, low BMI, vitamin D deficiency | DEXA, calcium/vitamin D, bisphosphonate/denosumab |
| Depression/anxiety | Breathlessness, isolation, mortality awareness | SSRIs, pulmonary rehab, palliative care integration |
